Pharmacokinetics of ertapenem in healthy young volunteers.
about
CarbapenemsThe pharmacokinetics and pharmacodynamics of the carbapanemes: focus on doripenemTDtest: easy detection of bacterial tolerance and persistence in clinical isolates by a modified disk-diffusion assay.Epileptogenic potential of carbapenem agents: mechanism of action, seizure rates, and clinical considerations.Antimicrobial breakpoints for gram-negative aerobic bacteria based on pharmacokinetic-pharmacodynamic models with Monte Carlo simulationCefoxitin as an alternative to carbapenems in a murine model of urinary tract infection due to Escherichia coli harboring CTX-M-15-type extended-spectrum β-lactamase.Pharmacokinetics and tolerability of single-dose intravenous ertapenem in infants, children, and adolescentsPenetration of ertapenem into muscle measured by in vivo microdialysis in mechanically ventilated patients.β-Lactams enhance daptomycin activity against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium in in vitro pharmacokinetic/pharmacodynamic models.Pharmacokinetics of total and unbound ertapenem in healthy elderly subjects.A 30-years review on pharmacokinetics of antibiotics: is the right time for pharmacogenetics?Use of Carbapenems against clinical, nontyphoid Salmonella isolates: results from in vitro and in vivo animal studies.Ertapenem: review of a new carbapenem.Tigecycline: a novel glycylcycline antibiotic.Intra-abdominal infections: considerations for the use of the carbapenems.Ertapenem: the new carbapenem 5 years after first FDA licensing for clinical practice.Carbapenems in the USA: focus on doripenem.Antimicrobial prophylaxis in colorectal surgery: focus on ertapenem.Ertapenem pharmacokinetics and impact on intestinal microflora, in comparison to those of ceftriaxone, after multiple dosing in male and female volunteers.Pharmacokinetics of ertapenem in critically ill patients receiving continuous venovenous hemodialysis or hemodiafiltration.Pharmacokinetics and pharmacodynamics of antibacterial and antifungal agents in adult patients with thermal injury: a review of current literature.Pharmacokinetics of ertapenem in colorectal tissue.A Critical Review of Analytical Methods for Determination of Ertapenem Sodium.Is there a role for microsampling in antibiotic pharmacokinetic studies?β-Lactams and β-Lactamase Inhibitors: An Overview.Pharmacokinetic Modeling and Limited Sampling Strategies Based on Healthy Volunteers for Monitoring of Ertapenem in Patients with Multidrug-Resistant Tuberculosis.A pharmacokinetic-pharmacodynamic model characterizing the emergence of resistant Escherichia coli subpopulations during ertapenem exposure.Design, synthesis, and evaluation of prodrugs of ertapenem.Sterilizing Effect of Ertapenem-Clavulanate in a Hollow-Fiber Model of Tuberculosis and Implications on Clinical Dosing.Integrated pharmacokinetic-pharmacodynamic modelling to evaluate antimicrobial prophylaxis in abdominal surgery.Quantification and validation of ertapenem using a liquid chromatography-tandem mass spectrometry method.Pharmacokinetics of ertapenem following intravenous and subcutaneous infusions in patients.Pharmacokinetics of ertapenem in outpatients with complicated urinary tract infections.Population pharmacokinetics of ertapenem in juvenile and old rats.Pharmacokinetics of Linezolid and Ertapenem in experimental parapneumonic pleural effusion.Comparative disposition of [14C]ertapenem, a novel carbapenem antibiotic, in rat, monkey and man.Penetration of ertapenem into different pulmonary compartments of patients undergoing lung surgery.The recommended dose of ertapenem poses a potential risk for central nervous system toxicity in haemodialysis patients - case reports and literature reviews.The Pharmacokinetics of 2000 mg Ertapenem in Tuberculosis Patients.Unbound fraction of ertapenem in intensive care unit patients.
P2860
Q28286055-96DD9115-CFC4-4B55-8197-7452B89C2A53Q28289744-252A4957-2E6A-4B16-90F2-0472CEA04589Q30837114-652076D6-D819-47E6-9D86-92B40EFB62C4Q34026343-B67BA067-C20F-4CA6-AE45-16B0453856D0Q34188814-CEB8BB06-C07A-46D0-8C17-B4A7867EE495Q34244192-871B5455-7679-4B80-95AE-BFCA76AF4E31Q34348830-0F435F7E-5E81-4B83-9FB3-BA25BE36F8C7Q35065899-5DC0DAA9-B065-48C8-8491-CD71746578AAQ35385108-4730F855-CB3A-43CF-8FE8-CC966E120621Q35547612-6BD07640-BF59-40D6-B01E-6FA7AE23729FQ35617587-D9154EC6-6733-4A32-A07B-FC6CC013A764Q36018937-BF16EB32-E50B-4F75-8C16-C1E076D6EA81Q36066200-3FFBBCD3-A73B-4AEF-9159-7DA1E2E84F03Q36379330-DADFB4FC-2618-4C44-9274-49D5599732D0Q36719679-08D87D81-C4B6-4A04-A0BD-8A25C4C9D9BAQ36719706-672463EF-ACA8-4547-A7C7-922BB901BB03Q36960048-34ADF018-3A45-4EBE-8843-EECA62C582A0Q37412959-A6B74987-FF3D-4E4B-8743-0581C98FED52Q37568571-820BCD5D-6422-4261-87D0-F65963283614Q37643628-216E8F81-655B-413B-B4B2-0FAD0DA88B57Q38244221-DB1AD11E-FFC5-4265-B473-9C961A7348B5Q38479091-E0005C2B-4AE2-4D99-BF1B-0BA6649168FEQ38726679-F4124739-19BF-4970-AFAA-4568F6088E4CQ38810590-4BA7E67C-CDE6-48F5-BF1E-765FC47687D9Q38872374-A07800EF-CA21-438C-9379-5D032DA7C057Q38991205-45F99C8B-C48E-470F-8B38-DFED916F0EB7Q39665401-ADBEA2E7-F35A-4E51-AA21-B85E714454F2Q39771519-BEE3F856-309D-4EF3-A967-F17ECF553B9CQ40139991-F22ADD5D-930B-4D14-9252-19997A37C2CBQ40617761-7F1FFF5A-F2BE-40B9-85D2-BD9986A6AE73Q41075817-5DF44A9C-238E-4F1A-A2F0-0BE7B01D6588Q41876999-567A8CC8-B79E-4CC1-9A6E-215563281516Q42216597-3B4BF024-E3E4-4E04-9562-1B9F950B711FQ42264085-F8EE3187-DBCA-456F-9ECC-B2DB11E4A639Q42744998-8BCE5D78-1267-4809-9E2D-EA68A26AAFC2Q44989494-482B1F2E-821B-48DA-94C9-914EA8826ADEQ46497112-D6A5294C-A1E8-4764-AEA3-60E589485E5BQ48156023-06270667-BF42-498E-B238-D0E890BFB1ECQ50028072-5CFA7036-29D7-4C12-99B3-A19A6EB1C14DQ52875965-E4095A61-9A67-4C63-A197-1359F09ED7C1
P2860
Pharmacokinetics of ertapenem in healthy young volunteers.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Pharmacokinetics of ertapenem in healthy young volunteers.
@ast
Pharmacokinetics of ertapenem in healthy young volunteers.
@en
Pharmacokinetics of ertapenem in healthy young volunteers.
@nl
type
label
Pharmacokinetics of ertapenem in healthy young volunteers.
@ast
Pharmacokinetics of ertapenem in healthy young volunteers.
@en
Pharmacokinetics of ertapenem in healthy young volunteers.
@nl
prefLabel
Pharmacokinetics of ertapenem in healthy young volunteers.
@ast
Pharmacokinetics of ertapenem in healthy young volunteers.
@en
Pharmacokinetics of ertapenem in healthy young volunteers.
@nl
P2093
P2860
P1476
Pharmacokinetics of ertapenem in healthy young volunteers
@en
P2093
A K Majumdar
C J Kitchen
D G Musson
H Greenberg
J D Rogers
P2860
P304
P356
10.1128/AAC.46.11.3506-3511.2002
P407
P577
2002-11-01T00:00:00Z